AI/ML Innovations Inc. AIML
Rating
Rating Factors
Company Overview
AI/ML Innovations Inc. (traded publicly under the ticker AIML on the Canadian Securities Exchange) is a Canadian technology-focused company operating in the artificial intelligence, machine learning, and digital health sectors. Based on publicly available disclosures and securities filings, the company focuses on acquiring, developing, and commercializing AI-enabled healthcare and wellness technologies, particularly those related to remote monitoring, predictive analytics, and digital diagnostics. Its business model has historically centered on building a portfolio of technology assets and subsidiaries rather than operating as a single-product enterprise.
The company’s primary areas of activity include AI-driven healthcare applications, biometric monitoring technologies, and software platforms intended to support preventative healthcare and patient engagement. Public disclosures indicate that AIML has pursued opportunities in remote patient monitoring and data-driven health analytics, positioning itself within the broader digital health and health technology market. Data regarding long-term market share, competitive ranking, or sustained profitability remains inconclusive based on available public sources.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
Valuation
Dividends and Shares
Corporate Info
25th Floor
700 West Georgia Street
PO Box 10026
Vancouver, BC V7Y 1B3